Researchers evaluated the long-term cardiovascular effects in children after treatment for MIS-C, a condition linked to COVID-19. They found that regardless of initial heart injury, most children displayed persistent cardiac abnormalities, underscoring the importance of ongoing cardiac monitoring post-recovery.
Which Anticoagulant Is Safest for Afib Patients With Cirrhosis?
Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a
July 9, 2024